- Home
- RAYA vs PLUR Comparison
RAYA vs PLUR Comparison
Compare RAYA & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- PLUR
- Stock Information
- Founded
- RAYA 2019
- PLUR 2001
- Country
- RAYA China
- PLUR Israel
- Employees
- RAYA N/A
- PLUR N/A
- Industry
- RAYA Metal Fabrications
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RAYA Consumer Discretionary
- PLUR Health Care
- Exchange
- RAYA Nasdaq
- PLUR Nasdaq
- Market Cap
- RAYA 4.3M
- PLUR 36.9M
- IPO Year
- RAYA 2022
- PLUR N/A
- Fundamental
- Price
- RAYA $3.72
- PLUR $3.54
- Analyst Decision
- RAYA
- PLUR Strong Buy
- Analyst Count
- RAYA 0
- PLUR 1
- Target Price
- RAYA N/A
- PLUR $12.00
- AVG Volume (30 Days)
- RAYA 63.4K
- PLUR 9.2K
- Earning Date
- RAYA 01-01-0001
- PLUR 11-11-2025
- Dividend Yield
- RAYA N/A
- PLUR N/A
- EPS Growth
- RAYA N/A
- PLUR N/A
- EPS
- RAYA N/A
- PLUR N/A
- Revenue
- RAYA $30,300,360.00
- PLUR $1,336,000.00
- Revenue This Year
- RAYA $20.95
- PLUR $97.38
- Revenue Next Year
- RAYA N/A
- PLUR $293.97
- P/E Ratio
- RAYA N/A
- PLUR N/A
- Revenue Growth
- RAYA 49.10
- PLUR 309.82
- 52 Week Low
- RAYA $3.65
- PLUR $3.33
- 52 Week High
- RAYA $737.00
- PLUR $7.13
- Technical
- Relative Strength Index (RSI)
- RAYA 44.44
- PLUR 34.32
- Support Level
- RAYA $4.80
- PLUR $3.60
- Resistance Level
- RAYA $5.00
- PLUR $4.00
- Average True Range (ATR)
- RAYA 0.40
- PLUR 0.18
- MACD
- RAYA -0.37
- PLUR -0.03
- Stochastic Oscillator
- RAYA 2.02
- PLUR 0.00
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.